Sunday, 19 April 2020

PCO




Your Web destination for the latest in Evidence based Obstetrics, Gynecology and Women’s health.
Saturday, December 24, 2016
Current options for ovulation induction in Polycystic Ovarian Syndrome (PCOS).
https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgGy7ORkAif_ctfEiml4DERyKkHgcf030LnhPDofk5wNpjsCUkbl2QY_02uuYOawilj13KbyjP85qBt7knvHmdwbLM1ZdHEx7G9Rx5XEAc5Nv8Yojwz3prCDhyphenhyphenS6ZoI8bhquLx5_LIpmu6Z/s400/PCOS.png
Image courtesy: pcosdatabase.org

Polycystic Ovarian Syndrome (PCOS) affects 1 in 10 women of childbearing age and have important metabolic and reproductive repercussion.[1] The treatment approach varies per the age of the patient, desire for pregnancy and the presenting symptoms.  

Approximately 80% of women who suffer from anovulatory infertility have PCOS. The treatment approaches towards ovulation induction varies per efficacy, patient BMI and other associated metabolic abnormalities.

A recent paper published in the December issue of Human Reproduction Update summarizes the evidence based recommendations for the management of anovulatoryinfertility in PCOS patients.[2] 

The evidence will form the basis for WHO to develop global guidelines. Management includes lifestyle changes, pharmacotherapy, bariatric surgery and laparoscopic surgery.

Lifestyle management, weight loss and exercise is recommended as the first line of treatment to improve general health and decrease insulin resistance. Morbidly obsess women should seek expert advice. At present, there is no evidence supporting the role of bariatric surgery in PCOS associated infertility. [3]



https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgjIIOFTNA7Uzm8hv-zBpCTRTPAdjoRY1nBnYpVt9GtHyD7YjMcSFKoh1skip2Tn9GGuEqaGzArRedscQ7NBNiKwzZZGpZpBZEbSKQqV5rZkrzZSl9T6poaaHUt_pD9SH8ZiJkoQ7UGB2iz/s400/pcos3.png
courtesy: iconfinder.com


Clomiphene citrate is recommended as primary agent to bring about ovulation. It is simple, inexpensive and induces ovulation in 75% of the patients.[4] Letrozole, an aromatase inhibitor is fast catching on clomiphene citrate as first place option.[5]

Metformin alone is not very effective in improving the live birth rates. It is added to clomiphene citrate regimen in older women with visceral obesity.  

Gonadotrophins and laparoscopic ovarian drilling are reserved as second line of treatment in patients who do not respond to lifestyle modification and oral therapies. Gonadotropin releasing hormone (GnRH) antagonist protocol is safe and combined with IVF. When GnRH agonist is the choice for treatment, metformin should be used as an adjunct to reduce the risk of ovarian hyperstimulation syndrome(OHSS).

Laparoscopic ovarian drilling is specifically used when there are other indications for laparoscopic surgery. It should not be used as first line of treatment. Concerns about long term effect of drilling on ovarian functions are still unanswered. [6]

IVF can be of use in those patients who do not respond to lifestyle modifications and oral ovulation induction drugs. It is specifically useful in those patients who also have additional causes for infertility.

No evidence supported the use of acupuncture or herbal remedies in ovulation induction. 









No comments:

Post a Comment